Haleon plc ADR (HLN)
NYSE: HLNConsumer DiscretionaryPackage Goods/CosmeticsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
HLN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $39.67B
- P/E (TTM)
- 18.41
- Forward P/E
- 14.59
- EPS (TTM)
- $0.49
- Dividend yield
- 0.81% ($0.073)
- Ex-dividend date
- Aug 14, 2026
- 52-week range
- 8.65 – 11.28
- Day range
- 9.01 – 9.16
- Volume / Avg
- 18.24M / 13.50M
- Beta
- —
- Shares outstanding
- 4.40B
- Next earnings
- Oct 29, 2026
52-week range
HLN stock today
Shares of Haleon (HLN) finished higher on Oct 7 at $9.02, a gain of 1.69% or $0.15 per share, versus the S&P 500's 0.22% decline. At this level, HLN sits near the bottom of its 52-week range of $8.65 to $11.28: 20.0% below the high, set on Feb 18, 2026 and 4.3% above the low. HLN is down 10.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 2.3%.
At 18.4x trailing earnings, Haleon trades below the peer-group median of 32.7x. Its forward P/E of 14.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Haleon's next earnings report is expected on Oct 29, 2026. Haleon pays an annual dividend of $0.073 per share, a 0.81% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Haleon
Company profileHaleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- CEO
- Mr. Brian James McNamara
- Headquarters
- Weybridge
- Employees
- 24,535
- IPO year
- 2022
- Website
- haleon.com
Analyst forecast
ForecastConsensus (5 analysts)
buy
Avg. price target
$11.93+32.26%
- Strong buy 2
- Buy 1
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Oct 29, 2026
Dividends
Dividend history- Annual dividend
- $0.073
- Dividend yield
- 0.81%
- Last payment
- $0.064
- Ex-dividend date
- Aug 14, 2026
HLN news
All HLN news- LCUT vs. HLN: Which Stock Is the Better Value Option?NasdaqLCUT, HLN
- Pre-Market Most Active for Sep 23, 2026 : IONQ, GRAB, SQQQ, TQQQ, GLND, NOK, NVDA, INTC, BMNR, BABA, HLN, BBNasdaqIONQ, GRAB, SQQQ, TQQQ
- Haleon takes advantage of GLP-1 side effects as US sales riseSeeking Alpha
- LCUT or HLN: Which Is the Better Value Stock Right Now?NasdaqLCUT, HLN
- Tuesday's ETF Movers: COPX, PPHNasdaqIE, ERO, NVS, HLN
- Haleon: Decent Growth Prospects, But Still Not A BargainSeeking Alpha
- LCUT vs. HLN: Which Stock Is the Better Value Option?NasdaqLCUT, HLN
- Haleon Completes Tender Offer For 2027 Notes, Sets Settlement For August 21Nasdaq
Haleon peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELEstee Lauder Companies Inc. (The) | 94.45 | +1.17% | $34.22B | vs HLN |
| KVUEKenvue Inc. | 17.53 | -0.34% | $33.67B | vs HLN |
| CHDChurch & Dwight Company Inc. | 96.75 | +0.22% | $22.95B | vs HLN |
| CLColgate-Palmolive Company | 87.21 | -0.05% | $69.52B | vs HLN |
| ELFe.l.f. Beauty Inc. | 105.03 | +2.18% | $6.20B | vs HLN |
| IPARInterparfums Inc. | 111.00 | -1.64% | $3.55B | vs HLN |
| COTYCoty Inc. Class A | 2.80 | +0.36% | $2.47B | vs HLN |
| SCLStepan Company | 61.32 | -1.72% | $1.39B | vs HLN |
Indexes, lists and sector
Appears in lists
Largest Consumer Discretionary stocks
Haleon stock FAQ
What is Haleon's stock price today?
HLN last traded at $9.02 as of Oct 7, 4:00 PM EDT, up 1.69% on the day. Prices are delayed at least 15 minutes.
Does Haleon pay a dividend?
Yes. Haleon pays $0.073 per share annually, a 0.81% yield. The most recent dividend of $0.064 had an ex-dividend date of Aug 14, 2026.
When is Haleon's next earnings date?
Haleon is expected to report earnings on Thursday, October 29, 2026.
What is HLN's P/E ratio?
HLN trades at a trailing P/E ratio of 18.41 and a forward P/E of 14.59, compared with a median of 32.7 for its closest peers.
Who is Haleon's CEO?
Mr. Brian James McNamara is the chief executive officer of Haleon plc ADR, which has about 24,535 employees.
What is the HLN 52-week high?
The 52-week high for HLN is $11.28 and the 52-week low is $8.65. The stock is currently 20.0% below its high.